VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 115 filers reported holding VBI VACCINES INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | -34.2% | 36,025 | -22.9% | 0.00% | – |
| Q2 2022 | $38,000 | -90.6% | 46,719 | -80.7% | 0.00% | -100.0% |
| Q1 2022 | $403,000 | -29.0% | 242,600 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $568,000 | -24.7% | 242,600 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $754,000 | -34.3% | 242,600 | -29.2% | 0.00% | 0.0% |
| Q2 2021 | $1,148,000 | +6.5% | 342,700 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $1,078,000 | +15.8% | 346,500 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $931,000 | +18.4% | 338,600 | +23.3% | 0.00% | 0.0% |
| Q3 2020 | $786,000 | -7.7% | 274,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $852,000 | +1344.1% | 274,700 | +1515.9% | 0.00% | – |
| Q1 2018 | $59,000 | -19.2% | 17,000 | 0.0% | 0.00% | – |
| Q4 2017 | $73,000 | +12.3% | 17,000 | 0.0% | 0.00% | – |
| Q3 2017 | $65,000 | -12.2% | 17,000 | 0.0% | 0.00% | – |
| Q2 2017 | $74,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |